By Josh White
Date: Monday 27 Mar 2023
(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.
By Josh White
Date: Friday 20 Jan 2023
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.
By Josh White
Date: Tuesday 04 Oct 2022
(Sharecast News) - Biotechnology company Allergy Therapeutics has "proactively paused" production at the Freeman facility, part of its Worthing manufacturing site, to accelerate ongoing site improvements, it announced on Tuesday.
| Currency | UK Pounds |
| Share Price | 8.20p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 8.75p |
| 52 Week Low | 5.00p |
| Volume | 519,307 |
| Shares Issued | 4,766.44m |
| Market Cap | £390.85m |
| RiskGrade | 268 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:05 | 100,000 @ 8.20p |
| 16:35 | 50,000 @ 8.20p |
| 16:35 | 20,000 @ 8.20p |
| 16:35 | 1 @ 8.20p |
| 16:35 | 29,999 @ 8.20p |
You are here: research